Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis-Reference-Cited by-同舟云学术

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis

Published:2018-02-19 Issue:4 Volume:67 Page:1348-1359
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Caussy Cyrielle¹²,Alquiraish Mosab H.¹,Nguyen Phirum¹,Hernandez Carolyn¹,Cepin Sandra¹,Fortney Lynda E.¹,Ajmera Veeral¹³^ORCID,Bettencourt Ricki¹,Collier Summer¹,Hooker Jonathan⁴,Sy Ethan⁴,Rizo Emily¹,Richards Lisa¹,Sirlin Claude B.⁴,Loomba Rohit¹³⁵

Affiliation:

1. NAFLD Research Center, Department of Medicine, University of California at San Diego; La Jolla CA

2. Université Lyon 1, Hospices Civils de Lyon; Lyon France

3. Division of Gastroenterology, Department of Medicine; La Jolla CA

4. Liver Imaging Group, Department of Radiology; University of California at San Diego; La Jolla CA

5. Division of Epidemiology, Department of Family and Preventive Medicine; University of California at San Diego; La Jolla CA

Funder

American Gastroenterological Association

Rohit Loomba serve as co-PIs

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute of Heath.

Publisher

Wiley

Subject

Hepatology

Reference52 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

3. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology,2011

4. Epidemiology and natural history of non-alcoholic fatty liver disease;Fazel;Metabolism,2016

5. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States;Charlton;Gastroenterology,2011

Cited by 272 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods and validation of velacur determined fat fraction in patients with MASLD;WFUMB Ultrasound Open;2024-12

2. A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL;Journal of Clinical and Experimental Hepatology;2024-09

3. Emerging Combination of Saroglitazar and Vitamin E for the Treatment of NAFLD and NASH;Journal of Clinical and Experimental Hepatology;2024-09

4. Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial;The American Journal of Clinical Nutrition;2024-09

5. Two-week continuous glucose monitoring-derived metrics and degree of hepatic steatosis: a cross-sectional study among Chinese middle-aged and elderly participants;Cardiovascular Diabetology;2024-08-31